This international conference will cover a vast range of topics, related to how “Engaging stakeholders for responsible stem cells research”. Its aim is to create a task force for improving the collaboration of  key stakeholders involved in the questions raised by the use of stem cells.

Argument

The European EUCelLEX Project (Cell-based regenerative medicine: new challenges for EU legislation and governance), lead by Emmanuelle Rial-Sebbag (Inserm UMR1027)consists in a full examination of the application of the European rules regarding cell banks together with current practices in respect of the therapeutic use of human cells in some European countries. This project aims at building and at organising a Task force on Stem Cells in Europe for collecting facts and figures to assess the current legislation on the therapeutic use of cells, and to bridge it with research infrastructure capacity building.

The EUCelLEX consortium and the European Association of Health Law (EAHL) are delighted to invite you at the EUCelLEX Final International Conference, to be held in Paris in September 2016, the 22nd and 23rd.

This International Conference will cover a vast range of topics, related to how “Engaging stakeholders for responsible Stem Cells research”. Our aim is to create a Task Force for improving the collaboration of  key stakeholders involved in the questions raised by the use of stem cells.

This event will be structured in two parties:

• On the 22nd of September, the EUCelLEX consortium will present the results of the analysis of the current European and national legislations in regards to the practices that are due to develop in the near future and will make recommendations to the European Commission. The program will consist of plenary sessions and round tables.
• On the 23rd of September, we will propose a joint workshop with the EAHL, about “Stem cells banking, legal conditions and governance issues“.

Conference attendance is free but requires registration. Attendees at the conference are invited to present a poster related to workshops topics.

Information

Updated information about this event can be found at https://www.eucellex.eu/final-international-conference

Programme

Thursday, 22 September 2016.

• 8:30 – 9:00 Registration & Welcome coffee.
• 9:00-10:00 Presentation of the EUCelLEX project final results. E Rial-Sebbag.
• 10:00-10:30 Coffee break.

10:30-11.15 Session 1: Stem Cells research, where are we?

• “Genome editing and Stem cells”. Dr Rosario Isasi, University of Miami Leonard M. Miller School of Medicine (USA).
• “Embryonic stem cells”. Dr Judit Sandor. Central European University (Hungary).
• “Update on innovative therapies regulation”. Dr Aurélie Mahalatchimy. University of Sussex (UK).
• “Stem cells and Societal issues”. Dr Andrew Webster. University of York (UK).

11:15. 12.30 Round Table 1. Do new technologies modify the bioethical principles for embryonic Stem Cell research?

• Participants of Session 1 and members of the EucelLEX project.

12:30 – 13:30 Lunch & Poster session.

13:30-15h15 Session 2: Stem cells National infrastructures

• Labex REVIVE (Institut Pasteur, France), by Dr Kenneth McElreaveay.
• UK Stem cell Bank, by Dr Glyn Stacey (to be confirmed).
• EBISC Project, by Dr Andreas Kurtz.
• Center for Medical Genetics (Japan), by Dr Tohru Masui.
• (Africa) (to be confirmed).

15:15-16:00 Round Table 2.Creating a European ELSI Task Force and beyond.

• Participants of Session 2 and:
• EuroStemCell contribution. One representative.
• Biotech company. One representative.

8:30-9:00 Welcome coffee.

9 :00-10:30 Stem cells banking: legal issues.

• Introduction of the key issues: Dr Berit Andersen Faber (Københavns Universitet, Denmark)
• Discussion: panel under construction

10 :30-11 :00 Coffee break.

11 :00-12:30 The Ethics of Stem cells banking

• Introduction of the key issues: Prof Sören Holm (University of Manchester, UK).
• Discussion: panel under construction

12 :30-13 :00 Conclusions.